Catalent Buyout Rumors

Source: Reuters

Apr 14, 2016

Switzerland-based CDMO, Lonza Group, has reportedly offered to acquire New Jersey-based Catalent, says Reuters sources.

Sources say the two companies have failed to agree on a price so far. Lonza is reportedly actively looking for acquisitions.

Lonza expanded its U.S. presence with several small biopharma purchases as well as purchasing Arch Chemicals in 2011. 

According to Bloomberg, Catalent had $1.83 billion in sales last year, with almost two-thirds coming from its oral technologies unit.

Read the Reuters coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments